Cancer FDA approves first drug to treat rare adrenal cancer Azedra has received FDA approval to become the first and only treatment for a type of rare adrenal cancer.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
